Matregenix Receives I-Corps Award from NIH

Irvine, California – Matregenix proudly announces that it has been honored with the I-Corps award from the National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health (NIH).

The I-Corps™ at NIH program is a transformative initiative aimed at equipping scientists with the skills and knowledge necessary to transition their research into successful entrepreneurial ventures. As a Phase I awardee, Matregenix will embark on an intensive 8-week program outside the laboratory, engaging in practical, hands-on training to thrive in the business world. This immersive experience includes a comprehensive blend of in-person and online courses, personalized mentoring, networking opportunities, and thorough market research. The program empowers participants to refine their business strategies, effectively identify target customers, and compellingly demonstrate the value of their innovations. including their Nanofiber Solutions. Moreover, Matregenix will receive $55,000 in funding to cover direct program costs, further bolstering their entrepreneurial endeavors.

"We are thrilled to receive this prestigious award, as it presents an incredible opportunity for us to collaborate closely with clinicians, gain valuable insights into their challenges, and validate our assumptions," exclaimed Dr. Soliman, CEO of Matregenix.

The I-Corps award from NIDCR marks a significant milestone in Matregenix's journey, propelling the company towards the forefront of the MedTech industry. This recognition not only validates their groundbreaking research but also acknowledges their potential to revolutionize the field of soft-tissue repair.

Disclaimer: Research presented in this publication has been generously supported by the National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health (NIH) under Award Number R43DE031984. The opinions, findings, and conclusions expressed herein are those of the authors and do not necessarily reflect the official views of the National Institutes of Health.

Matregenix, Inc. partners with Hodges International, Inc to Introduce their PFAS-Free Nanofiber Barrier Layer to the Active and Protective Apparel Industries
UC Irvine's Master of Engineering Capstone Project, Sponsored by Matregenix, Wins Top Dean's Choice Award